Leuk Lymphoma
Antineoplastic Combined Chemotherapy ProtocolsArsenicalsArsenic Trioxide
Daniel Budman
NPI1376673764
- Medicare services, 2019
- 236
- Part D claims, 2020
- 11
- Publications
- 149
- Clinical trials
- 3
- Industry payments
- $11,508
- Practice address
- 450 Lakeville Road, Lake Success, NY 11042
- Practice phone
- Call (516) 734-8958
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Daniel Budman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Daniel Budman is a hematologist and oncologist in Lake Success, New York
Daniel Budman practices in Lake Success, New York.
Daniel Budman's NPI, 1376673764, was assigned on March 6, 2007. Daniel Budman graduated from Albert Einstein College of Medicine in 1972. Daniel Budman's New York license number on file is 118120.
NPI and contact details
- NPI
- 1376673764NPI Registry (opens in a new tab)
- NPI enumeration date
- March 6, 2007
- NPI status
- Active
- Practice phone
- (516) 734-8958
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1972
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Daniel Budman's practice address is in Lake Success, New York
Daniel Budman's practice address in the NPI Registry is 450 Lakeville Road, Lake Success, NY 11042. The practice phone is (516) 734-8958.
- NPI Registry address450 Lakeville Road, Lake Success, NY 11042Phone(516) 734-8958
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Daniel Budman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Budman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Daniel Budman's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Daniel Budman practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Daniel Budman is one of 996 hematologists and oncologists in New York
Hematology and oncology is Daniel Budman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Daniel Budman's licenses on file in 4 states: New York, Colorado, Nevada and Pennsylvania.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
- Colorado license
- Nevada license
- Pennsylvania license
Hematologists and oncologists near Daniel Budman
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
996hematologists and oncologists in New York
2hematologists and oncologists in Lake Success
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Daniel Budman billed Medicare for 236 services in 2019
CMS data shows 236 Medicare services from Daniel Budman across 3 procedure codes in 2019. Medicare paid $17,662 for them.
Medicare services, 2019236
Paid by Medicare$17,662
Procedure codes3
Daniel Budman's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Office and hospital visits
- 2018: 2922019: 23619%
Where Daniel Budman's Medicare services took place, 2019
- In an office22495%
- In a facility125%
Daniel Budman compared with the New York median for hematologists and oncologists, 2019
- Daniel Budman
- New York median
- Medicare services
- 236vs 66865% below
- Part D claims
- 11vs 25896% below
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Daniel Budman's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Daniel Budman?
Medicare shows one payer. Book a meeting to get commercial claims data for Daniel Budman and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Daniel Budman's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Daniel Budman's median patient age at 74, with 100% women.
Daniel Budman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Daniel Budman wrote 11 Medicare Part D claims in 2020
In 2020, Daniel Budman wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $378 in total drug cost. In 2019, CMS named 203 claims across 6 drugs.
Part D claims, 202011
Drugs named by CMS1
Total drug cost$378
Daniel Budman's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 2032020: 1195%
Drugs named by CMS: 1 in 2020, 6 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Daniel Budman by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Daniel Budman has 149 publications on record
Dmand AI links 149 papers to Daniel Budman, published from 2002 to 2021. 2013 was the busiest year, with 7. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Antineoplastic Agents. Daniel Budman has published most often in J Clin Oncol. Daniel Budman's most frequent co-authors are Steven L. Allen, Larry Norton, MD and Jonathan E. Kolitz, MD.
Papers149
Years published2002 to 2021
Daniel Budman's papers by year, 2008 to 2021
Topics Daniel Budman writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Antineoplastic Agents
- Drug Evaluation
- Doxorubicin
- Cyclophosphamide
- Tumor Cells, Cultured
- Paclitaxel
Daniel Budman's most frequent co-authors
Recent publications by Daniel Budman
Antineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsChemotherapy, Adjuvant
Antibodies, BispecificAntibodies, Monoclonal
Adjuvants, ImmunologicAntineoplastic Agents, HormonalBreast Neoplasms
See who Daniel Budman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Daniel Budman works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Daniel Budman has worked on 3 clinical trials
Dmand AI links Daniel Budman to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Breast Neoplasms, Breast Diseases and Thromboembolism. Northwell Health sponsors the most, 2.
Clinical trials with Daniel Budman by phase
- 1Phase 1: 1 trial
- NonePhase 2: no trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Daniel Budman's trials
- Breast Neoplasms
- Breast Diseases
- Thromboembolism
- Embolism and Thrombosis
Investigators on the most trials with Daniel Budman
- Mitchell B. Alden, DO1 shared trial
- Bruce J. Averbook, MD1 shared trial
- Shehzad Aziz, MD1 shared trial
Recent clinical trials with Daniel Budman
A Phase I Study of the Safety and Tolerability of Single Agent MSI-1436C in Metastatic Breast Cancer Patients (opens in a new tab)
TerminatedPhase 1
Breast NeoplasmsBreast DiseasesMSI-1436C
Breast NeoplasmsBreast DiseasesBevacizumabIxabepiloneNab-paclitaxel
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism (opens in a new tab)
TerminatedPhase 3
ThromboembolismEmbolism and ThrombosisArixtra aloneArixtra + filter
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Daniel Budman received $11,508 in industry payments from 2016 to 2020
CMS Open Payments shows 8 general payments to Daniel Budman from 4 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 96% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $5,715.
General payments to Daniel Budman by program year, 2016 to 2020
General payments to Daniel Budman by kind, 2016 to 2020
$11.5Kin total
- Consulting fees$11,00296%
- Travel and lodging$4874%
- Food and beverage$190%
Companies that paid Daniel Budman the most, 2016 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Daniel Budman has 1 award and honors on record
Dmand AI lists 1 award for Daniel Budman.
Awards and honors for Daniel Budman
- Undated
- Super Doc
Source: Dmand AI Professional Profile Data
Daniel Budman graduated from Albert Einstein College of Medicine
Daniel Budman graduated from Albert Einstein College of Medicine in 1972. Daniel Budman is a member of Allliance (CALGB), AOA, ACP, ASCO, ASH and European Society of Clinical Oncology.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Daniel Budman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Daniel Budman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Daniel Budman's NPI number?
Daniel Budman's NPI number is 1376673764. It was assigned on March 6, 2007, and it is active in the NPI Registry.
What does Daniel Budman specialize in?
Daniel Budman is a hematologist and oncologist in Lake Success, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Daniel Budman practice?
Daniel Budman practices at 450 Lakeville Road, Lake Success, NY 11042.
What is Daniel Budman's office phone number?
The practice phone on file for Daniel Budman is (516) 734-8958.
What is Daniel Budman's medical license number?
Daniel Budman's New York license number on file is 118120, one of the licenses on file in 4 states.
Which states has Daniel Budman been licensed in?
Dmand AI has state licenses on file for Daniel Budman in New York (1973 to 2021), Colorado (2000 to 2027), Nevada (1974 to 2014) and Pennsylvania (1973 to 1976).
Does Daniel Budman accept Medicare?
Yes. CMS data shows Daniel Budman billed Medicare for 236 services in 2019.
What services does Daniel Budman bill to Medicare?
In 2019, Daniel Budman's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and hospital inpatient care (99223).
Where did Daniel Budman go to medical school?
Daniel Budman graduated from Albert Einstein College of Medicine in 1972.
What drugs does Daniel Budman prescribe most?
In 2020 Medicare Part D data, Daniel Budman's most prescribed drugs by claims were Anastrozole.
Show 4 more questionsShow fewer questions
Has Daniel Budman received payments from drug or device companies?
CMS Open Payments shows $11,508 in general payments to Daniel Budman from 4 companies from 2016 to 2020. The largest total came from Bayer HealthCare Pharmaceuticals Inc.
How long has Daniel Budman been practicing?
Daniel Budman graduated from medical school in 1972, 54 years ago.
Does Daniel Budman do research?
Dmand AI links 149 publications to Daniel Budman, published from 2002 to 2021. Daniel Budman has worked on 3 clinical trials.
Who does Daniel Budman publish with?
Daniel Budman's most frequent co-authors are Steven L. Allen (14 shared papers), Larry Norton, MD (9 shared papers) and Jonathan E. Kolitz, MD (8 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card